ADDENDUM TO THELicense and Technology Transfer Agreement • May 4th, 2007 • Evergreen Solar Inc • Semiconductors & related devices
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • September 5th, 2024 • England
This License And Technology Transfer Agreement is made and entered into on this 20th day of November, 2015 (Effective Date) by and between:
EX-10.20 9 dex1020.htm LICENSE AND TECHNOLOGY TRANSFER AGREEMENT CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF...License and Technology Transfer Agreement • May 5th, 2020 • California
This License and Technology Transfer Agreement (the “Agreement”) effective this 21st day of December, 2007 (the “Effective Date”) by and between Ariane Controls inc., (“Ariane”) and Enphase Energy Inc., (“Enphase”). (Ariane and Enphase may be referred to individually as a “Party” and collectively as the “Parties”).
RECEPTOS CONFIDENTIAL LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • April 16th, 2013 • Receptos, Inc. • Pharmaceutical preparations • New York
This License and Technology Transfer Agreement (the “Agreement”) is made as of December 28, 2010 (the “Effective Date”) by and between Receptos, Inc., a Delaware corporation (“Receptos”) located at 10835 Road to the Cure, Suite #205, San Diego, California 92121 and Ortho-McNeil-Janssen Pharmaceuticals, Inc., a Pennsylvania corporation (“Company”) having an address at 1125 Trenton-Harbour Road, Titusville, New Jersey 08650.
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • July 1st, 2004 • Netlogic Microsystems Inc • Semiconductors & related devices • New York
This LICENSE AND TECHNOLOGY TRANSFER AGREEMENT (this “Agreement”), dated as of December 12, 2002 (the “Effective Date”) and amended as of May 7, 2003, is made by and between Micron Technology, Inc., a Delaware corporation (“MTI”) and NetLogic Microsystems, Inc., a Delaware corporation (“NetLogic”), (each of NetLogic and MTI, a “Party”; together the “Parties”).
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • June 14th, 2022 • New York
This License and Technology Transfer Agreement is made and entered into as of the 15th day of June, 2022 (Effective Date) by and between:
LICENSE AND TECHNOLOGY TRANSFER AGREEMENT For EMIRATES SIMULATION ACADEMYLicense and Technology Transfer Agreement • October 4th, 2006 • Gse Systems Inc • Services-prepackaged software
LICENSE AGREEMENT ANDLicense and Technology Transfer Agreement • February 1st, 2024 • Redwoods Acquisition Corp. • Biological products, (no disgnostic substances)
Universitat Autònoma de Barcelona (hereinafter, “UAB”), an institution organized as a university under the laws of Spain, with registered offices at Campus de la UAB, Plaza Cívica, s/n, 08193 Bellaterra, Spain, provided with Tax Identification number (CIF), Q-0818002-H, duly represented by Dr. Armando Sánchez Bonastre, acting in his capacity as Vice-rector for Research and Transfer of UAB, appointed by the Rector on November 13, 2020; and by virtue of the Resolution of November 23, 2020 for the present purposes and by virtue of the provisions of Article 75 of the Statutes of the UAB, approved by Decree 237/2003 of October 8, of the Generalitat de Catalunya;
License and Technology Transfer AgreementLicense and Technology Transfer Agreement • November 5th, 2018 • PTC Therapeutics, Inc. • Pharmaceutical preparations
Type of Contract License and Technology Transfer Agreement (Research and development results belong solely to NTU) Contract No. □□□□□□□□□ Licensed Technology □□□□□□□□□□□□□□□□□
License and Technology Transfer Agreement Amendment No. 2 (“Amendment No. 2”) Effective Date: Dec. 1, 2019License and Technology Transfer Agreement • March 2nd, 2020 • PTC Therapeutics, Inc. • Pharmaceutical preparations
WHEREAS, Party A and Party B entered in to a certain License and Technology Transfer Agreement with Agilis BioTherapeutics, LLC, NTU Contract No.: 104-I0TC-10, dated December 23, 2015 (the “Agreement”);
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • November 12th, 2010 • Sunpower Corp • Semiconductors & related devices • California
This LICENSE AND TECHNOLOGY TRANSFER AGREEMENT (“Agreement”) is made and entered into as of July 5, 2010, by and among (i) SunPower Technology, Ltd., a company organized under the laws of the Cayman Islands (“SPTL”); (ii) AU Optronics Singapore Pte. Ltd., a company organized under the laws of Singapore (“AUO”); and (iii) SunPower Malaysia Manufacturing SDN.BHD., a company organized under the laws of Malaysia (the “JVC”). Each of SPTL, AUO and the JVC may be referred to herein as a “Party” and together as the “Parties.”
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • June 15th, 2011 • Enphase Energy, Inc. • California
This License and Technology Transfer Agreement (the “Agreement”) effective this 21st day of December, 2007 (the “Effective Date”) by and between Ariane Controls inc., (“Ariane”) and Enphase Energy Inc., (“Enphase”). (Ariane and Enphase may be referred to individually as a “Party” and collectively as the “Parties”).
License and Technology Transfer AgreementLicense and Technology Transfer Agreement • November 21st, 2011 • Gulf Shores Investments, Inc. • Real estate operators (no developers) & lessors
WHEREAS, Party A desire to grant and transfer the TRIOP technology to Party B to implement such technology in the territories as defined below.
LICENSE AND TECHNOLOGY TRANSFER AGREEMENT between CIDARA THERAPEUTICS, INC. and JANSSEN PHARMACEUTICALS, INC. April 23, 2024License and Technology Transfer Agreement • August 13th, 2024 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This License and Technology Transfer Agreement (this “Agreement”), dated as of April 23, 2024 (the “Execution Date”), is entered into by and between Cidara Therapeutics, Inc., a Delaware corporation, having an address of 6310 Nancy Ridge Drive, Suite 101, San Diego, CA 92121 (“Cidara”), and Janssen Pharmaceuticals, Inc., a corporation organized and existing under the laws of Pennsylvania, with its principal business office located at 1125 Trenton-Harbourton Road, Titusville, NJ 08560 (“Janssen”). Cidara and Janssen are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • December 12th, 2013 • England
Each of BMS and MPP is referred to in this Agreement as a Party. BMS and MPP are collectively referred to in this Agreement as the Parties.
ContractLicense and Technology Transfer Agreement • May 5th, 2020
<DOCUMENT> <TYPE>EX-4.12 <SEQUENCE>4 <FILENAME>irm124d.txt <DESCRIPTION>LICENSE AND TECHNOLOGY TRANSFER AGREEMENT <TEXT> LICENSE AND TECHNOLOGY TRANSFER AGREEMENT THIS AGREEMENT (the "Agreement") dated as of March 1, 2002 is by and between HAEMACURE CORPORATION, a corporation organized and existing under the laws of Quebec, Canada having its main office at 2001 University Street, Suite 430, Montreal, Canada 43A2AG, (hereinafter referred to as "HAE") and ZLB BIOPLASMA AG, a wholly-owned subsidiary of CSL Limited, and a corporation organized and existing under the laws of Switzerland, having its main office and place of business at Wankdorfstrasse 10, of 3000 Bern 22, (hereinafter referred to as "ZLB Bioplasma"), (HAE and ZLB Bioplasma are hereinafter jointly referred to as "the Parties"). RECITALS: WHEREAS, HAE and ZLB Central Laboratory Blood Transfusion Service SRC (hereinafter referred to as "ZLB Foundation") entered into a License Agreement and a Supply Agreement (the "1999 Agreemen
Contract No.: _______________ License and Technology Transfer Agreement LICENSED TECHNOLOGY NAME Licensor: National Sun Yat-sen University Inventor: Professor __________________ Licensee: _____________________________ Co., Ltd. Technology Transfer and...License and Technology Transfer Agreement • May 5th, 2020
WHEREAS, Party B has developed, invented, and/or made the practical technology through utilizing resources and research facilities provided by Party A.
